The global fusion biopsy market is expected to grow from USD 429.33 million in 2019 to USD 882.19 million by 2027, at a CAGR of 9.42% during the forecast period 2020-2027.
Fusion biopsy is the technique that combines the ultrasound and MRI scan for creating a detailed three-dimensional image of prostate cancer. This technique helps to locate the abnormal tissue present in the different organs. The tissue which is found to be abnormal can then be easily removed and checked for any signs of cancer under the microscope. Fusion biopsy is found to be the most effective method for the diagnosis of prostate cancer. There are several pieces of research that have shown the accuracy of fusion biopsy over the traditional biopsy methods. It enables early diagnosis of cancer, which results in effective treatment and better chances of recovering. The most beneficial feature is that it eliminates the need for continuous biopsy sessions. The increasing cases of prostate cancer, coupled with the growing demand for fusion biopsy diagnosis, have driven the market growth over the years.
This study delivers a comprehensive analysis of the biopsy route, end-users and regions. The biopsy route segment includes transperineal and transrectal. Among the two, the transrectal segment accounted for the major market shares in 2019. A transrectal biopsy involves removing an abnormal tissue with the help of a needle inserted into the rectum and then in the prostate. The commercial availability of transrectal is more than the transperineal segment. It is the most used biopsy route in the treatment of prostate cancer. The end-user segment includes hospitals, ambulatory care centers and diagnostic centers. Among these, hospitals constitute major market shares. Hospitals witness a higher number of patients visiting. Moreover, the availability of highly skilled professionals and better facilities has contributed to the overall market share of the segment.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America had the largest market share in 2019. The region has witnessed an upsurge in prostate cancer cases. Further, the increasing research and development expenditure for prostate cancer has led to the growth of the fusion biopsy market in the region.
Some of the notable players in the fusion biopsy market are MedCom, KOELIS, Focal Healthcare, UC-Care Medical Systems Ltd., Siemens Healthineers USA, Invivo Corporation, Hologic, ESAOTE SPA, Koninklijke Philips N.V., GeoScan Medical, C. R. Bard, Precision Biopsy, B.D., Merit Medical Systems Inc. and others.
This study forecasts revenue growth at global, regional, and country levels from 2020 to 2027. Fior Markets has segmented the market based on the below-mentioned segments:
Global Fusion Biopsy Market Analysis And Forecast, By Biopsy Route
Global Fusion Biopsy Market Analysis And Forecast, By End-users
Global Fusion Biopsy Market Analysis And Forecast, By Region
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Biopsy Route
4.3.2. Market Attractiveness Analysis By End-users
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing prevalence of prostate cancer
5.2.2. Use of advanced technology
5.3. Restraints
5.3.1. High cost of fusion software
5.4. Opportunities
5.4.1. Supportive government initiatives
5.5. Challenges
5.5.1. Lack of skilled professionals
6. Global Fusion Biopsy Market Analysis and Forecast, By Biopsy Route
6.1. Segment Overview
6.2. Transperineal
6.3. Transrectal
7. Global Fusion Biopsy Market Analysis and Forecast, By End-users
7.1. Segment Overview
7.2. Hospitals
7.3. Ambulatory Care Centres
7.4. Diagnostic Centers
8. Global Fusion Biopsy Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Fusion Biopsy Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Fusion Biopsy Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. MedCom
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. KOELIS
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Focal Helathcare
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. UC-Care Medical Systems Ltd.
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Siemens Healthineers USA
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Invivo Corporation
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Hologic
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Koninklijke Philips N.V.
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. GeoScan Medical
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. C. R. Bard
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. Precision Biopsy
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Product Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. BD
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Product Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
10.13. Merit Medical Systems Inc.
10.13.1. Business Overview
10.13.2. Company Snapshot
10.13.3. Company Market Share Analysis
10.13.4. Company Product Portfolio
10.13.5. Recent Developments
10.13.6. SWOT Analysis
10.14. ESAOTE SPA
10.14.1. Business Overview
10.14.2. Company Snapshot
10.14.3. Company Market Share Analysis
10.14.4. Company Product Portfolio
10.14.5. Recent Developments
10.14.6. SWOT Analysis
List of Table
1. Global Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
2. Global Transperineal, Fusion Biopsy Market, By Region, 2019-2027 (USD Millions)
3. Global Transrectal, Fusion Biopsy Market, By Region, 2019-2027 (USD Millions)
4. Global Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
5. Global Hospitals, Fusion Biopsy Market, By Region, 2019-2027 (USD Millions)
6. Global Ambulatory Care Centres, Fusion Biopsy Market, By Region, 2019-2027 (USD Millions)
7. Global Diagnostic Centers, Fusion Biopsy Market, By Region, 2019-2027 (USD Millions)
8. North America Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
9. North America Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
10. U.S. Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
11. U.S. Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
12. Canada Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
13. Canada Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
14. Mexico Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
15. Mexico Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
16. Europe Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
17. Europe Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
18. Germany Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
19. Germany Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
20. France Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
21. France Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
22. U.K. Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
23. U.K. Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
24. Italy Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
25. Italy Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
26. Spain Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
27. Spain Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
28. Asia Pacific Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
29. Asia Pacific Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
30. Japan Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
31. Japan Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
32. China Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
33. China Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
34. India Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
35. India Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
36. South America Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
37. South America Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
38. Brazil Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
39. Brazil Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
40. Middle East and Africa Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
41. Middle East and Africa Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
42. UAE Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
43. UAE Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
44. South Africa Fusion Biopsy Market, By Biopsy Route, 2019-2027 (USD Millions)
45. South Africa Fusion Biopsy Market, By End-users, 2019-2027 (USD Millions)
List of Figures
1. Global Fusion Biopsy Market Segmentation
2. Global Fusion Biopsy Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Fusion Biopsy Market Attractiveness Analysis By Biopsy Route
9. Global Fusion Biopsy Market Attractiveness Analysis By End-users
10. Global Fusion Biopsy Market Attractiveness Analysis By Region
11. Global Fusion Biopsy Market: Dynamics
12. Global Fusion Biopsy Market Share by Biopsy Route (2020 & 2027)
13. Global Fusion Biopsy Market Share by End-users (2020 & 2027)
14. Global Fusion Biopsy Market Share by Regions (2020 & 2027)
15. Global Fusion Biopsy Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.